8-Oxo-7,8-dihydro-2′-deoxyguanosine
(8-oxo-dG), an oxidized
form of guanosine residues, is a critical biomarker for various cancers.
Herein, a sensitive citrate-capped gold nanoparticle-based aptasensor
device has been developed for the detection of 8-oxo-dG in urine.
We previously designed a 38-nt anti-8-oxo-dG-aptamer by a computer
simulation and the experimental validation has been performed in the
present work. The analytical performance of the 38-nt aptamer from
the
in silico
design was compared with the parent
66-nt aptamer. This assay is based on the principle of salt-induced
aggregation of citrate-capped gold nanoparticles. Based on this sensing
mechanism, the difference between the absorbance in the presence and
absence of 8-oxo-dG at λ = 525 nm (ΔA525) increased linearly
as a function of 8-oxo-dG concentrations in the ranges of 10–100
and 15–100 nM for 38-nt and 66-nt aptasensors, respectively.
This method can provide detection limits of 6.4 nM for 8-oxo-dG in
the 38-nt aptasensor and 13.2 nM in the 66-nt aptasensor. Similar
to the 66-nt aptamer, the shortened aptamer, 38-nt long, can provide
high sensitivity and selectivity with rapid detection time. In addition,
using the 38-nt aptamer as a recognition component in the developed
portable low-cost device showed high sensitivity in the detection
range of 15–100 nM with a detection limit of 12.9 nM, which
is much lower than the threshold value (280 nM) for normal human urine.
This easy-to-use device could effectively and economically be utilized
for monitoring 8-oxo-dG in real urine samples and potentially serve
as a prototype for a commercial device.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.